ArticleEuropean heart journal2022

Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?

Kai Jakobs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.